Central Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 3/6
Central Pharmaceuticals has a total shareholder equity of BDT850.2M and total debt of BDT286.6M, which brings its debt-to-equity ratio to 33.7%. Its total assets and total liabilities are BDT1.5B and BDT665.9M respectively.
Key information
33.7%
Debt to equity ratio
৳286.60m
Debt
| Interest coverage ratio | n/a |
| Cash | ৳1.18m |
| Equity | ৳850.24m |
| Total liabilities | ৳665.94m |
| Total assets | ৳1.52b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CENTRALPHL's short term assets (BDT449.4M) exceed its short term liabilities (BDT382.2M).
Long Term Liabilities: CENTRALPHL's short term assets (BDT449.4M) exceed its long term liabilities (BDT283.7M).
Debt to Equity History and Analysis
Debt Level: CENTRALPHL's net debt to equity ratio (33.6%) is considered satisfactory.
Reducing Debt: CENTRALPHL's debt to equity ratio has increased from 11.5% to 33.7% over the past 5 years.
Debt Coverage: CENTRALPHL's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if CENTRALPHL's interest payments on its debt are well covered by EBIT.